Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Journal of Vascular and Interventional Radiology : JVIR|March 29, 2006
The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinomaIhab R Kamel, David A Bluemke, John Eng, et al.Diseases of the Colon and Rectum|January 5, 2023
Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete ResponseSamuel H Lai, Jon D Vogel, Sudheer Vemuru, et al.British Journal of Cancer|September 8, 2017
Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancerAkiko Matsumoto, John Arcaroli, Ying Chen, et al.Investigational New Drugs|March 27, 2014
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinomaAna De Jesus-Acosta, Daniel Laheru, Anirban Maitra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2016
Phase I Study of the Investigational Anti-Guanylyl Cyclase Antibody-Drug Conjugate TAK-264 (MLN0264) in Adult Patients with Advanced Gastrointestinal MalignanciesKhaldoun Almhanna, Thea Kalebic, Cristina Cruz, et al.JOP : Journal of the Pancreas|June 29, 2018
Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic AdenocarcinomaBrandon C Chapman, Ana Gleisner, Devin Rigg, et al.Journal of Surgical Oncology|March 24, 2017
Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancerBrandon C Chapman, Patrick Hosokawa, William Henderson, et al.Journal of Vascular and Interventional Radiology : JVIR|June 4, 2013
Metaanalysis of survival, complications, and imaging response following chemotherapy-based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinomaCharles E Ray, Anthony Edwards, Mitchell T Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid TumorsAntonio Jimeno, Michael Gordon, Rashmi Chugh, et al.Annals of Surgical Oncology|September 10, 2017
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase InhibitorVictor Manuel Villalobos, Francis Hall, Antonio Jimeno, et al.Pageof 5